VAERS 2317311
JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 211AUA
- Staat
- IL
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 13.06.2022
- Impfdatum
- 29.09.2021
- Beginn
- 06.06.2022
- Tage bis Beginn
- 250,0
- Dosis
- 1
- Route/Site
- IM / RA
Symptomtext
Patient received J&J x 1 on 9/29/21. Presented to ER on 6/6/22 and found to be covid positive. Was admitted. Workup included COVID-19 testing which was positive. He was mildly hypoxic. He has significant risk factors with COPD with continued nicotine addiction. Was started on remdesivir and dexamethasone as well supplemental oxygen per protocol, appropriate quarantine, and azithromycin and ceftriaxone. Was started on Breo Ellipta. Initially was in the ICU. Of note had 1 J and J vaccine but no booster. Over the next 72 hours he improved and was titrated off oxygen by discharge. Was counseled repeatedly regarding smoking cessation. In regards to syncope had echocardiogram which was unremarkable and was on telemetry without issues. Had no further episodes. Blood pressure medications were held tried his hospital stay but by the time of discharge blood pressure was starting to elevate. By the above date he was tolerating his usual activity and discharged home. Discharged on 6/10/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 4,0
- Labordaten
- 6/6/22 COVID19: positive 6/6/22 chest xray: Apparent mild airspace disease within the right lung base and retrocardiac region. Mild pneumonia or aspiration is questioned.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 2. Hyperlipidemia 3. Hypertension 4. Extensive nicotine addiction 5. Respiratory issues that include significant morning coughing 6. "I have touch of emphysema" 7. BPH
- Andere Medikamente
- aspirin EC 81 MG Tbec 81 mg, Oral, DAILY atorvastatin 40 MG Tabs Commonly known as: LIPITOR 40 mg, Oral, DAILY fish oil-omega-3 fatty acids 1000 MG Caps 1,000 mg, Oral, DAILY losartan 100 MG Tabs Commonly known as: COZAAR 100 mg, Oral
- Allergien
- none
- Vorherige Impfungen
- -